NOD2 Variants and Antibody Response to Microbial Antigens in Crohn's Disease Patients and Their Unaffected Relatives

Gastroenterology

Volumn 132, Issue 2, 2007, Pages 576-586

  Devlin, Shane M ^a   Yang, Huiying ^a   Ippoliti, Andrew ^a   Taylor, Kent D ^a   Landers, Carol J ^a   Su, Xiaowen ^a   Abreu, Maria T ^b   Papadakis, Konstantinos A ^a   Vasiliauskas, Eric A ^a   Melmed, Gil Y ^a   Fleshner, Phillip R ^a   Mei, Ling ^a   Rotter, Jerome I ^a   Targan, Stephan R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIAL PROTEIN; DNA; FLAGELLIN; MANNAN; OUTER MEMBRANE PROTEIN; PORIN C; PROTEIN CBIR1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE; GENE LOCUS; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MAJOR CLINICAL STUDY; NOD2 GENE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS FLUORESCENS; QUANTITATIVE ANALYSIS; RELATIVE; T LYMPHOCYTE;

EID: 33847016160     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.11.013     Document Type: Article

References (70)

1. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 347 (2002) 417-429
2. Cobrin G.M., and Abreu M.T. Defects in mucosal immunity leading to Crohn's disease. Immunol Rev 206 (2005) 277-295
3. Strober W., Fuss I.J., and Blumberg R.S. The immunology of mucosal models of inflammation. Annu Rev Immunol 20 (2002) 495-549
4. De Winter H., Cheroutre H., and Kronenberg M. Mucosal immunity and inflammation. II. The yin and yang of T cells in intestinal inflammation: pathogenic and protective roles in a mouse colitis model. Am J Physiol 276 (1999) G1317-G1321
5. Cong Y., Weaver C.T., Lazenby A., and Elson C.O. Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12. J Immunol 165 (2000) 2173-2182
6. Cong Y., Brandwein S.L., McCabe R.P., Lazenby A., Birkenmeier E.H., Sundberg J.P., and Elson C.O. CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med 187 (1998) 855-864
7. Cong Y., Weaver C.T., Lazenby A., and Elson C.O. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol 169 (2002) 6112-6119
8. Brandwein S.L., McCabe R.P., Cong Y., Waites K.B., Ridwan B.U., Dean P.A., Ohkusa T., Birkenmeier E.H., Sundberg J.P., and Elson C.O. Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J Immunol 159 (1997) 44-52
9. Kim S.C., Tonkonogy S.L., Albright C.A., Tsang J., Balish E.J., Braun J., Huycke M.M., and Sartor R.B. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128 (2005) 891-906
10. Prantera C., Zannoni F., Scribano M.L., Berto E., Andreoli A., Kohn A., and Luzi C. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 91 (1996) 328-332
11. Prantera C., Kohn A., Zannoni F., Spimpolo N., and Bonfa M. Metronidazole plus ciprofloxacin in the treatment of active, refractory Crohn's disease: results of an open study. J Clin Gastroenterol 19 (1994) 79-80
12. Prantera C., Kohn A., Mangiarotti R., Andreoli A., and Luzi C. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen. Am J Gastroenterol 89 (1994) 513-518
13. Rutgeerts P., Hiele M., Geboes K., Peeters M., Penninckx F., Aerts R., and Kerremans R. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108 (1995) 1617-1621
14. Steinhart A.H., Feagan B.G., Wong C.J., Vandervoort M., Mikolainis S., Croitoru K., Seidman E., Leddin D.J., Bitton A., Drouin E., Cohen A., and Greenberg G.R. Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial. Gastroenterology 123 (2002) 33-40
15. Rutgeerts P., Goboes K., Peeters M., Hiele M., Penninckx F., Aerts R., Kerremans R., and Vantrappen G. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338 (1991) 771-774
16. D'Haens G.R., Geboes K., Peeters M., Baert F., Penninckx F., and Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114 (1998) 262-267
17. Mow W.S., Landers C.J., Steinhart A.H., Feagan B.G., Croitoru K., Seidman E., Greenberg G.R., and Targan S.R. High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study. Dig Dis Sci 49 (2004) 1280-1286
18. Main J., McKenzie H., Yeaman G.R., Kerr M.A., Robson D., Pennington C.R., and Parratt D. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ 297 (1988) 1105-1106
19. Quinton J.F., Sendid B., Reumaux D., Duthilleul P., Cortot A., Grandbastien B., Charrier G., Targan S.R., Colombel J.F., and Poulain D. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42 (1998) 788-791
20. Sutton C.L., Kim J., Yamane A., Dalwadi H., Wei B., Landers C., Targan S.R., and Braun J. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology 119 (2000) 23-31
21. Cohavy O., Bruckner D., Gordon L.K., Misra R., Wei B., Eggena M.E., Targan S.R., and Braun J. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun 68 (2000) 1542-1548
22. Landers C.J., Cohavy O., Misra R., Yang H., Lin Y.C., Braun J., and Targan S.R. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 123 (2002) 689-699
23. Targan S.R., Landers C.J., Yang H., Lodes M.J., Cong Y., Papadakis K.A., Vasiliauskas E., Elson C.O., and Hershberg R.M. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 128 (2005) 2020-2028
24. Seibold F., Stich O., Hufnagl R., Kamil S., and Scheurlen M. Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study. Scand J Gastroenterol 36 (2001) 196-201
25. Glas J., Torok H.P., Vilsmaier F., Herbinger K.H., Hoelscher M., and Folwaczny C. Anti-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value. Digestion 66 (2002) 173-177
26. Annese V., Andreoli A., Andriulli A., Dinca R., Gionchetti P., Latiano A., Lombardi G., Piepoli A., Poulain D., Sendid B., and Colombel J.F. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study. Am J Gastroenterol 96 (2001) 2407-2412
27. Vermeire S., Peeters M., Vlietinck R., Joossens S., Den Hond E., Bulteel V., Bossuyt X., Geypens B., and Rutgeerts P. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 7 (2001) 8-15
28. Sutton C.L., Yang H., Li Z., Rotter J.I., Targan S.R., and Braun J. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 46 (2000) 58-63
29. Sendid B., Quinton J.F., Charrier G., Goulet O., Cortot A., Grandbastien B., Poulain D., and Colombel J.F. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 93 (1998) 1306-1310
30. Mei L., Targan S.R., Landers C.J., Dutridge D., Ippoliti A., Vasiliauskas E.A., Papadakis K.A., Fleshner P.R., Rotter J.I., and Yang H. Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease. Gastroenterology 130 (2006) 1078-1085
31. Beckwith J., Cong Y., Sundberg J.P., Elson C.O., and Leiter E.H. Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens. Gastroenterology 129 (2005) 1473-1484
32. Russell R.K., Nimmo E.R., and Satsangi J. Molecular genetics of Crohn's disease. Curr Opin Genet Dev 14 (2004) 264-270
33. Mathew C.G., and Lewis C.M. Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 13 (2004) R161-R168
34. Watts D.A., and Satsangi J. The genetic jigsaw of inflammatory bowel disease. Gut 50 Suppl 3 (2002) III31-III36
35. Noble C.L., Nimmo E.R., Drummond H., Ho G.T., Tenesa A., Smith L., Anderson N., Arnott I.D., and Satsangi J. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 129 (2005) 1854-1864
36. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., Olson J.M., Lee J.C., Beaugerie L., Naom I., Dupas J.L., Van Gossum A., Orholm M., Bonaiti-Pellie C., Weissenbach J., Mathew C.G., Lennard-Jones J.E., Cortot A., Colombel J.F., and Thomas G. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379 (1996) 821-823
37. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., and Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
38. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., and Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
39. Inohara N., Ogura Y., and Nunez G. Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol 5 (2002) 76-80
40. Gutierrez O., Pipaon C., Inohara N., Fontalba A., Ogura Y., Prosper F., Nunez G., and Fernandez-Luna J.L. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 277 (2002) 41701-41705
41. Rosenstiel P., Fantini M., Brautigam K., Kuhbacher T., Waetzig G.H., Seegert D., and Schreiber S. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124 (2003) 1001-1009
42. Lala S., Ogura Y., Osborne C., Hor S.Y., Bromfield A., Davies S., Ogunbiyi O., Nunez G., and Keshav S. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 125 (2003) 47-57
43. Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., and Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276 (2001) 4812-4818
44. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nunez G., and Flavell R.A. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
45. Shaw S.H., Hampe J., White R., Mathew C.G., Curran M.E., and Schreiber S. Stratification by CARD15 variant genotype in a genome-wide search for inflammatory bowel disease susceptibility loci. Hum Genet 113 (2003) 514-521
46. Lesage S., Zouali H., Cezard J.P., Colombel J.F., Belaiche J., Almer S., Tysk C., O'Morain C., Gassull M., Binder V., Finkel Y., Modigliani R., Gower-Rousseau C., Macry J., Merlin F., Chamaillard M., Jannot A.S., Thomas G., and Hugot J.P. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70 (2002) 845-857
47. Sugimura K., Taylor K.D., Lin Y.C., Hang T., Wang D., Tang Y.M., Fischel-Ghodsian N., Targan S.R., Rotter J.I., and Yang H. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet 72 (2003) 509-518
48. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M., Foster S.J., Moran A.P., Fernandez-Luna J.L., and Nunez G. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 278 (2003) 5509-5512
49. Li J., Moran T., Swanson E., Julian C., Harris J., Bonen D.K., Hedl M., Nicolae D.L., Abraham C., and Cho J.H. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet 13 (2004) 1715-1725
50. Pierik M., Joossens S., Van Steen K., Van Schuerbeek N., Vlietinck R., Rutgeerts P., and Vermeire S. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 12 (2006) 1-8
51. Oostenbrug L.E., Drenth J.P., de Jong D.J., Nolte I.M., Oosterom E., van Dullemen H.M., van der Linde K., te Meerman G.J., van der Steege G., Kleibeuker J.H., and Jansen P.L. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis 11 (2005) 567-575
52. Brand S., Staudinger T., Schnitzler F., Pfennig S., Hofbauer K., Dambacher J., Seiderer J., Tillack C., Konrad A., Crispin A., Goke B., Lohse P., and Ochsenkuhn T. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm Bowel Dis 11 (2005) 645-652
53. Franchimont D., Vermeire S., El Housni H., Pierik M., Van Steen K., Gustot T., Quertinmont E., Abramowicz M., Van Gossum A., Deviere J., and Rutgeerts P. Deficient host-bacteria interactions in inflammatory bowel disease?. The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53 (2004) 987-992
54. Torok H.P., Glas J., Tonenchi L., Bruennler G., Folwaczny M., and Folwaczny C. Crohn's disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology 127 (2004) 365-366
55. Mow W.S., Vasiliauskas E.A., Lin Y.C., Fleshner P.R., Papadakis K.A., Taylor K.D., Landers C.J., Abreu-Martin M.T., Rotter J.I., Yang H., and Targan S.R. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 126 (2004) 414-424
56. Abreu M.T., Taylor K.D., Lin Y.C., Hang T., Gaiennie J., Landers C.J., Vasiliauskas E.A., Kam L.Y., Rojany M., Papadakis K.A., Rotter J.I., Targan S.R., and Yang H. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 123 (2002) 679-688
57. The International HapMap Project. Nature 426 (2003) 789-796
58. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
59. Armitage P., Berry G., and Matthews J.N.S. Statistical methods in medical research (2005), Blackwell, Malden, MA
60. Chamaillard M., Philpott D., Girardin S.E., Zouali H., Lesage S., Chareyre F., Bui T.H., Giovannini M., Zaehringer U., Penard-Lacronique V., Sansonetti P.J., Hugot J.P., and Thomas G. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci U S A 100 (2003) 3455-3460
61. Walker L.J., Aldhous M.C., Drummond H.E., Smith B.R., Nimmo E.R., Arnott I.D., and Satsangi J. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol 135 (2004) 490-496
62. Arnott I.D., Landers C.J., Nimmo E.J., Drummond H.E., Smith B.K., Targan S.R., and Satsangi J. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 99 (2004) 2376-2384
63. Annese V., Lombardi G., Perri F., D'Inca R., Ardizzone S., Riegler G., Giaccari S., Vecchi M., Castiglione F., Gionchetti P., Cocchiara E., Vigneri S., Latiano A., Palmieri O., and Andriulli A. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease-an IG-IBD study. Am J Gastroenterol 100 (2005) 84-92
64. Cruyssen B.V., Peeters H., Hoffman I.E., Laukens D., Coucke P., Marichal D., Cuvelier C., Remaut E., Veys E.M., Mielants H., De Vos M., and De Keyser F. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients. Clin Exp Immunol 140 (2005) 354-359
65. Goodarzi M.O., Taylor K.D., Guo X., Quinones M.J., Cui J., Li X., Hang T., Yang H., Holmes E., Hsueh W.A., Olefsky J., and Rotter J.I. Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait. Diabetes 54 (2005) 1222-1227
66. Motulsky A.G., and Brunzell J.D. Genetics of coronary atherosclerosis. In: King R.A., Rotter J.I., and Motulsky A.G. (Eds). The genetic basis of common disease. 2nd ed. (2002), Oxford University Press, New York, NY 105-126
67. Cario E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut 54 (2005) 1182-1193
68. Arnott I.D., Nimmo E.R., Drummond H.E., Fennell J., Smith B.R., MacKinlay E., Morecroft J., Anderson N., Kelleher D., O'Sullivan M., McManus R., and Satsangi J. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?. Genes Immun 5 (2004) 417-425
69. Gazouli M., Mantzaris G., Kotsinas A., Zacharatos P., Papalambros E., Archimandritis A., Ikonomopoulos J., and Gorgoulis V.G. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 11 (2005) 681-685
70. Thjodleifsson B., Sigthorsson G., Cariglia N., Reynisdottir I., Gudbjartsson D.F., Kristjansson K., Meddings J.B., Gudnason V., Wandall J.H., Andersen L.P., Sherwood R., Kjeld M., Oddsson E., Gudjonsson H., and Bjarnason I. Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives?. Gastroenterology 124 (2003) 1728-1737